Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Why are people not putting the Bashers on Ignore? Painful.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Craigbadon Aug 18, 2016 9:23pm
74 Views
Post# 25156947

RE:Why are people not putting the Bashers on Ignore? Painful.

RE:Why are people not putting the Bashers on Ignore? Painful.Quite simply, the people critical of the company and exposing the flaws have been nothing but right. The people pumping buyouts and strong fundamentals have been wrong and have cost people an untold forune of hard earned money they will have a hard time recovering from. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities